filmov
tv
Future developments in targeted cell therapies for autoimmune diseases
Показать описание
Samik Basu, MD, Cabaletta Bio, Philadelphia, PA, provides a brief overview of cell therapies under development at Cabaletta Bio for various autoimmune diseases, including muscle-specific tyrosine kinase (MuSK) myasthenia gravis, and mucosal and mucocutaneous pemphigus vulgaris. Cell therapies for progressive membranous nephropathy, mediated by PLA2R-positive antibodies, are additionally under investigation. This interview took place at Advanced Therapies Week 2022.
0:00:44
0:03:19
0:05:53
0:06:52
0:00:35
0:14:32
0:01:38
0:05:40
0:00:09
0:16:28
0:56:52
0:07:44
0:01:21
0:51:50
0:29:16
0:00:58
0:10:14
0:07:33
0:58:01
0:04:46
0:03:33
0:00:39
0:04:33
0:00:50